Gender Disparities in Clinical Decision Making
Gender Disparities in Clinical Decision Making
复制标题
临床决策中的性别差异
DOI：
--
复制
发表时间：
1991
期刊：
影响因子：
--
通讯作者：
K. A. Halkola
中科院分区：
文献类型：
--
作者：
R. McMurray;O. Clarke;John A. Barrasso;D. Clohan;C. H. Epps;J. Glasson;Robert McQuillan;C. W. Plows;M. A. Puzak;D. Orentlicher;K. A. Halkola
最近的证据引起了人们的关注，即由于对妇女保健问题的研究、诊断和治疗重视不足，妇女处于不利地位。1985年，美国公共卫生局妇女健康问题特别工作组报告说，由于缺乏关于妇女的研究数据，限制了对妇女健康需求的了解。1 .令人关切的是，对妇女的医疗是以男性模式为基础的，而不顾妇女对治疗的反应可能与男子不同，或者某些疾病在妇女身上的表现与在男子身上的表现不同。对男性的医学研究结果一概而论适用于女性，没有足够的证据证明适用于女性。2-4例如，关于阿司匹林预防冠状动脉疾病价值的原始研究几乎完全来自于对男性的研究，然而，基于这项研究的建议已被指向
RECENT evidence has raised concerns that women are disadvantaged because of inadequate attention to the research, diagnosis, and treatment of women's health care problems. In 1985, the US Public Health Service's Task Force on Women's Health Issues reported that the lack of research data on women limited understanding of women's health needs. 1 One concern is that medical treatments for women are based on a male model, regardless of the fact that women may react differently to treatments than men or that some diseases manifest themselves differently in women than in men. The results of medical research on men are generalized to women without sufficient evidence of applicability to women. 2-4 For example, the original research on the prophylactic value of aspirin for coronary artery disease was derived almost exclusively from research on men, yet recommendations based on this research have been directed to
影响因子：
39.2
作者：
TOBIN, JN;WASSERTHEILSMOLLER, S;WACHSPRESS, J
通讯作者：
WACHSPRESS, J